Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02223299

Pilot Study: Combining Nutritional Supplements With Standard Antidepressant to Treat Depression.

A Randomized Double-Blind Placebo-Controlled Pilot Study of L-tyrosine and L-tryptophan in Depressed Patients Receiving L-methylfolate and and SSRI

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
John D. Dingell VA Medical Center · Federal
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

\*\*This study never received IRB approval and no participants were ever enrolled\*\* The purpose of this study is to determine if adding over the counter nutritional supplements will have a benefit to participants currently taking prescribed antidepressants who have not experienced complete remission of their depression symptoms.

Detailed description

Inclusion Criteria: Detroit VA Patients with major depression, mild to moderate treated with an SSRI and not having complete remission of symptoms as defined by "feeling their normal selves" Randomized into two groups: Experimental: will receive month supply of deplin 15mg, L-tyrosine 6g/d into 2 divided doses, and L-tryptophan 2g/d into 2 divided doses. Control: will receive month supply of deplin 15mg , and 2 placebo pills. Beck Depression Scale (BDI-2) to be administered at baseline and every 2 weeks for 1 month.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTL-tyrosine6g/d daily for 30 days
DIETARY_SUPPLEMENTL-Tryptophan2g/d daily for 30 days
DRUGdeplin15mg daily for 30 days
OTHERPlacebo Aa sugar-pill that looks like a real medication
OTHERPlacebo Ba sugar-pill that looks like a real medication

Timeline

Start date
2015-11-01
Primary completion
2015-11-01
Completion
2015-11-01
First posted
2014-08-22
Last updated
2020-02-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02223299. Inclusion in this directory is not an endorsement.